Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BTIG Initiates Coverage On Embecta with Neutral Rating

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.
byBenzinga Newsdesk
September 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

IPA Responds To 13D Filing By Ingalls & Snyder, LLC; IPA Announced That It Has Recently Begun Interviewing Potential Candidates To Refresh Its Board Of Directors In Its Search For The Optimal Board Composition

By Benzinga Newsdesk
August 9, 9:19 AM
IPA responds to 13D Filing by Ingalls & Snyder, LLCIPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an advanced biotherapeutic research and technology company, today issued the following

IPA